Age (y; Salari Paper) | Age (y; New Resultsa) | ||||||
---|---|---|---|---|---|---|---|
Study | Year | Groups (Salari Paper) | Groups (New Resultsa) | Mean | SD | Mean | SD |
Apovian [9] | 2013 | Placebo | Placebo | 44.4 | 11.4 | 44.4 | 11.4 |
Naltrexone + bupropion | 32 mg/day naltrexone SR + 360 mg/day bupropion SR (NB32) | 44.3 | 11.2 | 44.3 | 11.2 | ||
Aronne [10] | 2010 | Placebo | Placebo | 42 | 11 | 42 | 11 |
Pramlintide | Pramlintide (120 µg sc) | 42 | 11 | 42 | 11 | ||
Pramlintide (120 µg sc t.i.d.) + sibutramine (10 mg oral q.a.m.) | 43 | 11 | |||||
Pramlintide (120 µg sc t.i.d.) + phentermine (37.5 mg oral q.a.m.) | 39 | 10 | |||||
Davies [7] | 2015 | Placebo | Placebo | 54.7 | 9.8 | 54.7 | 9.8 |
Liraglutide 0.3 mg | Liraglutide 3.0 mg | 55 | 10.8 | ||||
Liraglutide 1.8 mg | Liraglutide 1.8 mg | 54.9 | 10.7 | ||||
Fidler [11] | 2011 | Placebo | Placebo | 43.7 | 11.8 | 43.7 | 11.8 |
Lorcaserin 10 mg BID | Lorcaserin 10 mg BID | 43.8 | 11.8 | 43.8 | 11.8 | ||
Lorcaserin 10 mg QD | Lorcaserin 10 mg QD | 43.8 | 11.7 | 43.8 | 11.7 | ||
Gadde [12] | 2011 | Placebo | Placebo | 51.2 | 10.25 | 51.2 | 10.25 |
Phentermine 7.5 mg + topiramate 46.0 mg | Phentermine 7.5 mg + topiramate 46.0 mg | 51.1 | 10.43 | 51.1 | 10.43 | ||
Phentermine 15.0 mg + topiramate 92.0 mg | Phentermine 15.0 mg + topiramate 92.0 mg | 51 | 10.65 | 51 | 10.65 | ||
Greenway [8] | 2010 | Placebo | Placebo | 43.7 | 11.1 | 43.7 | 11.1 |
Naltrexone + bupropion 16.0 mg | Naltrexone16.0 mg + bupropion | 44.4 | 11.3 | 44.4 | 11.3 | ||
Naltrexone + bupropion 32.0 mg | Naltrexone32.0 mg + bupropion | 44.4 | 11.1 | 44.4 | 11.1 | ||
Le Roux [13] | 2017 | Placebo | Placebo | 47.3 | 11.8 | 47.3 | 11.8 |
Liraglutide | Liraglutide 3.0 mg | 47.5 | 11.7 | 47.5 | 11.7 | ||
Lu [14] | 2018 | Placebo | Placebo | 37 | 10 | 37 | 10 |
Lorcaserin | Lorcaserin 10.0 mg | 34.7 | 9 | 34.7 | 9 | ||
O’Neil [15] | 2012 | Placebo | Placebo | 53.2 | 8.3 | 52 | 9.3 |
Orlistat 120.0 mg BID | Lorcaserin 10 mg BID | 53.9 | 8.1 | 53.2 | 8.3 | ||
Orlistat 120.0 mg QD | Lorcaserin 10 mg QD | 53.5 | 7.4 | 53.1 | 8 | ||
Pi-Sunyer [16] | 2015 | Placebo | Placebo | 45.2 | 12.1 | 45 | 12 |
Liraglutide | Liraglutide 3.0 mg QD | 45 | 12 | 45.2 | 12.1 | ||
Smith [17] | 2010 | Placebo | Placebo | 44.4 | 0.3 | 44.4 | 0.3 |
Lorcaserin | Lorcaserin 10.0 mg | 43.8 | 0.3 | 43.8 | 0.3 |